http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP088217-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
filingDate | 2008-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f96f51b5214f8089f8961d580d6cb2b |
publicationDate | 2008-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EC-SP088217-A |
titleOfInvention | FORMS OF CRYSTAL DELTA AND EYESILON MESILATE IMATINIB |
abstract | The invention relates to the delta and epsilon crystal form of the methanesulfonic acid addition salt of 4- (4-methyl-piperazin-1-yl-methyl) -N- [4-methyl-3- ( 4- (pyridin-3-yl) -pyrimidin-2-yl-amino) -phenyl] -benzamide (the compound of the formula I, see below), to certain processes for its preparation, to pharmaceutical compositions containing these forms crystal, and for use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, and for use as an intermediary or for the preparation of pharmaceutical preparations for use in diagnostic methods or for the therapeutic treatment of blood animals Hot, especially humans. |
priorityDate | 2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.